This CME activity is planned to meet the needs of the following practicing healthcare professionals: psychiatrists, psychologists, primary care physicians, nurses, residents, medical students, social workers, counselors, mid-level practitioners and other behavioral health professionals.
Program Objectives:
1. Review the research underlying new technologies for addressing treatment resistant depression
2. Review new research and concepts for existing interventions
3. Discuss the implementation of both new and existing technologies in clinical practice
Agenda:
*40-45 minute talks (allowing room for questions)
8:00-8:15 a.m. – Welcome and Introduction
8:15-9:00 a.m. – Erik Nelson, MD – “Update on the Pharmacology of Treatment Resistant Depression”
9:05-9:50 a.m. – Scott Ries, MSW, LISW-S – “Psychotherapeutic Challenges in Working with Treatment Resistant Depression”
9:50-10:10 a.m. – BREAK
10:10-10:55 a.m. – Cheryl McCullumsmith, MD, PhD – “Ketamine for Treatment Resistant Depression and Suicidal Ideation”
11:00-11:45 a.m. – Stephen Rush, MD – “Neuromodulation and Depression”
11:45-12 p.m. – Concluding Remarks and Adjournment
You can also download the morning agenda.
Registration:
- Fees$75 per person in advance; $90/person at the door. Cash, check or credit card accepted for advance registration. Only checks will be accepted at the door.
- Medical students and residents – Free with prior registration; $25 at the door.
To register, call Christina Gibson at (513) 558-4866 or e-mail at christina.gibson@uc.edu.
**Registration is ONLY needed for the AM session!! The afternoon session is FREE! Download the afternoon session agenda.
